The Centers for Disease Control and Prevention (CDC) awarded a sole source purchase order to CEM Corporation, a for-profit small business and manufacturer of specialized laboratory equipment, for the provision of maintenance and support services for the CEM Liberty Blue Peptide Synthesizer. This $21,735.64 firm fixed-price contract has an ultimate completion date of August 19, 2025. The purchase order was awarded on August 19, 2024 under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1),...
This is a $95,700 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit company specializing in DNA synthesis solutions and laboratory equipment. The contract is for the procurement of a DR.OLIGO 48 DNA synthesizer, which allows the CDC to synthesize oligonucleotides at a much higher capacity with reduced turnaround time and argon gas consumption. This sole-source contract is based...
This is a sole-source firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to CEM Corporation, doing business as CEM Corp, for maintenance and service of CEM Peptide Synthesizers, including the Discover, Liberty Blue, and Discover S-CLASS models. The contract has a potential value of $104,190.50 and a completion date of August 19, 2024. CEM Corporation is a manufacturer of analytical and synthetic chemistry laboratory...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the maintenance of a medium throughput DNA synthesizer and related reagents. The contract, valued at $54,000.00, has an ultimate completion date of September 25, 2025. Biolytic Lab Performance Inc. is the prime contractor, and there is no set-aside designation for this award. The company has a proven track...
This federal contract award, with an ID of HHSD2002015M88042P, was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Bioautomation Corporation, a for-profit manufacturer, for the procurement of a MERMADE DNA Synthesizer. The contract is a firm fixed-price purchase order with a ceiling value of $93,940.00 and an ultimate completion date of February 28, 2016. The contract does not have a set-aside designation. Bioautomation...
The Centers for Disease Control and Prevention (CDC) awarded a $25,700 Firm Fixed Price purchase order to Bruker Scientific LLC, a division of Bruker Corporation, to provide one-year maintenance services for a Bruker Sirius Biotyper Matrix-assisted Laser Desorption/Ionization time of flight mass spectrometer. This contract was awarded without a set-aside and is scheduled for completion by September 15, 2025. The original contract opportunity was issued as a Special Notice, under the authority of...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $70,428.08 contract is for the provision of a QuantStudio QS7ProDx 96 0.2mL block system, a commercial item that will support the CDC's Parasitic Diseases Branch. This requirement was solicited as a combined synopsis/solicitation under Simplified Acquisition Procedures, with no...
This is a purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Biotage, LLC, a manufacturer of analytical chemistry equipment and consumables. The contract is for the delivery of a solid phase liquid handler, a specialized laboratory instrument, with a firm fixed price of $137,137.00. The contract does not have a set-aside designation. Biotage has a long history of supplying a variety of analytical instruments and services,...
The Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to Life Technologies Corporation for the procurement of two QuantStudio 5Dx Real-Time Polymerase Chain Reaction (PCR) Systems and associated accessories. The contract has a ceiling value of $121,206.26 and a completion date of August 20, 2024. This is a commercial item acquisition conducted under Simplified Acquisition Procedures and is not a set-aside. Life Technologies Corporation is a manufacturer...
This is a sole source purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agilent Technologies Inc. for the procurement of Oligo Pro II supplies or services. The contract action is being pursued under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1), which allows for sole source procurement without competition. The key requirements include fast separations, wide sizing range, single base resolution through 60-mers, variable throughput, and direct...